hCB1(2)

Nomenclature

C57BL/6JSmo-Cnr1tm2(hCNR1)Smoc

Cat. NO.

NM-HU-250165

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Cnr1

Model Description

The endogenous mouse Cnr1 gene was replaced by human CNR1 gene.

Validation Data

image.png

Fig.1 Detection of CNR1 expression in cerebellum by RT-PCR. Cerebellum RNA was extracted from wild-type C57BL/6 mice and homozygous hCB1(2) knockin mice, then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human mRNA primers (n=2, male, 7 weeks old). Mouse Cnr1 mRNA (373 bp) was detectable only in wild-type C57BL/6 mice. Human CNR1 mRNA (209 bp) was detectable only in homozygous hCB1(2) knockin mice but not in wild-type mice. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.2 Detection of CNR1 expression in muscle, heart, kidney, epididymal White Adipose Tissue (eWAT of male) and gonadal White Adipose Tissue (gWAT of female) by RT-PCR. Mouse Cnr1 mRNA (373 bp) was detectable only in wild-type C57BL/6 mice. Human CNR1 mRNA (209 bp) was detectable only in homozygous hCB1(2) knockin mice but not in wild-type mice. Tissues RNA was extracted from 7-week-old male and female wild-type C57BL/6 (WT)(n=4) and homozygous hCB1(2) knockin mice (HO) (n=4), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.  

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.3 Detection of CB1 expression in hCB1(2) mice by WB. CB1 was detectable in eWAT/gWAT, iWAT, muscle, kidney and heart from both WT C57BL/6 and HO hCB1(2) mice , as the antibody was cross-reactived between human and mouse CB1. The eWAT/gWAT, iWAT, muscle, kidney and heart tissue lysates were collected from 6-7-week-old wild-type C57BL/6 mice and 7-week-old homozygous hCB1(2) mice, and then analyzed by western blot with anti-CB1 antibody. 

Abbr. HO, homozygous; WT, wild type; M, marker; WAT, white adipocyte tissue; PC, mouse brain tissue lysates.


You may also like

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more